Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Nicotine, Nicotinic agonist, Dopamine, Levodopa, Parkinson's disease, and Medial forebrain bundle.
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
α7 nicotinic receptor agonists reduce levodopa‐induced dyskinesias with severe nigrostriatal damage
The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions
ABT‐089 and ABT‐894 reduce levodopa‐induced dyskinesias in a monkey model of Parkinson's disease
Varenicline enhances dopamine release facilitation more than nicotine after long‐term nicotine treatment and withdrawal
α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
Long‐term nicotine treatment down‐regulates α6β2* nicotinic receptor expression and function in nucleus accumbens
The nicotine‐mediated decline in <scp>l</scp>‐dopa‐induced dyskinesias is associated with a decrease in striatal dopamine release
Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice